In a filing, Sana Biotechnology Inc revealed its Officer NATHAN HARDY acquired Company’s shares for reported $0.18 million on Oct 21 ’24. In the deal valued at $3.95 per share,45,796 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mulligan Richard sold 150,000 shares, generating $612,570 in total proceeds. Upon selling the shares at $4.08, the Director now owns 2,848,121 shares.
Before that, Mulligan Richard sold 150,000 shares. Sana Biotechnology Inc shares valued at $583,170 were divested by the Director at a price of $3.89 per share. As a result of the transaction, Mulligan Richard now holds 2,698,121 shares, worth roughly $9.15 million.
JMP Securities downgraded its Sana Biotechnology Inc [SANA] rating to a Mkt perform from a a Mkt outperform in a research note published recently. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering SANA and has increased its forecast on January 16, 2024 with a “Buy” recommendation from previously “Neutral” rating. JMP Securities started covering the stock on September 25, 2023. It rated SANA as “a Mkt outperform”.
Price Performance Review of SANA
On Tuesday, Sana Biotechnology Inc [NASDAQ:SANA] saw its stock fall -9.84% to $3.39. Over the last five days, the stock has lost -10.32%. Sana Biotechnology Inc shares have fallen nearly -16.91% since the year began. Nevertheless, the stocks have fallen -3.97% over the past one year. While a 52-week high of $12.00 was reached on 03/01/24, a 52-week low of $3.06 was recorded on 11/05/24. SMA at 50 days reached $4.37, while 200 days put it at $6.60.
Levels Of Support And Resistance For SANA Stock
The 24-hour chart illustrates a support level at 2.98, which if violated will result in even more drops to 2.57. On the upside, there is a resistance level at 3.67. A further resistance level may holdings at 3.95. The Relative Strength Index (RSI) on the 14-day chart is 34.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.11%. Stochastics %K at 30.71% indicates the stock is a holding.
How much short interest is there in Sana Biotechnology Inc?
A steep rise in short interest was recorded in Sana Biotechnology Inc stocks on 2024-10-15, growing by 2.11 million shares to a total of 33.28 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 31.17 million shares. There was a rise of 6.34%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 05, 2023 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
